Endocrine dysfunction following immune checkpoint inhibitor therapy
Current Opinion in Endocrinology, Diabetes and Obesity Sep 08, 2017
Konda B, et al. - In this case-based review, the physicians intended to present clinical presentation, diagnosis, and management strategies of immune-related endocrinopathies associated with immune checkpoint inhibitors use. The results of this study displayed that immune checkpoint inhibitors use is associated with serious endocrinopathies that may have a nonspecific initial presentation. In addition, a constant eye for these symptoms and a systematic approach to diagnosis are essential for prompt initiation of therapy and prevention of significant complications.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries